RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cost-effectiveness analysis of belimumab for the treatment of adults with active lupus nephritis in China
Wu, B., He, X., Tang, Z., Martin, A., Bracher, M., Guo, N., & Campbell, K. (2024). Cost-effectiveness analysis of belimumab for the treatment of adults with active lupus nephritis in China. Value in Health, 27(6), S77. Article EE106. https://doi.org/10.1016/j.jval.2024.03.405